Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Mt, Calvo"'
Autor:
Jm, Grasa Ullrich, Torres Gómez M, Sánchez-Marín B, Marcuello Melendo B, Mt, Calvo, José Antonio García-Erce, Giralt Raichs M
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5128efefd8825f8d95d9393e29570049
http://europepmc.org/abstract/med/12200003
http://europepmc.org/abstract/med/12200003
Autor:
Sánchez-Martín B, Jm, Grasa, Latorre A, Ma, Montañés, José Antonio García-Erce, Torres M, Mt, Calvo, Giralt M
Publikováno v:
Europe PubMed Central
Cerebral venous thrombosis (CVT) is considered to be a relative unusual pathology, probably underdiagnosed. Many acquired and inherited hypercoagulability states (HS) have been described as cause of CVT.[corrected] We evaluated the incidence of acqui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a4020cba3bb6f0d3c38c840023fc500a
http://europepmc.org/abstract/med/12396970
http://europepmc.org/abstract/med/12396970
Autor:
Gris-Oliver A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Ibrahim YH; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Rivas MA; Department of Medicine, Weil Cornell Medicine, New York, NY, USA., García-García C; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Ruiz-Pace F; Oncology Data Science (ODysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain., Viaplana C; Oncology Data Science (ODysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain., Pérez-García JM; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Barcelona, Spain.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Madrid, Spain., Llombart-Cussac A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA., Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Parés M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Anton P; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Cozar P; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Calvo MT; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Bruna A; Preclinical Modelling of Paediatric Cancer Evolution Team, Institute of Cancer Research, Sutton, UK., Arribas J; Growth Factors Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, Bellaterra, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Caldas C; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Dienstmann R; Oncology Data Science (ODysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain., Nuciforo P; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Oliveira M; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Cortés J; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. jacortes@vhio.net.; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. jacortes@vhio.net.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Barcelona, Spain. jacortes@vhio.net.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Madrid, Spain. jacortes@vhio.net.; Breast Cancer GroupVall d'Hebron Institute of Oncology, Barcelona, Spain. jacortes@vhio.net., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. vserra@vhio.net.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Apr; Vol. 124 (9), pp. 1581-1591. Date of Electronic Publication: 2021 Mar 15.
Autor:
Béguelin W; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA. Electronic address: web2002@med.cornell.edu., Teater M; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Meydan C; Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Hoehn KB; Department of Pathology, Yale School of Medicine, New Haven, CT 06520, USA., Phillip JM; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Soshnev AA; Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY 10065, USA., Venturutti L; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Rivas MA; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Calvo-Fernández MT; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Gutierrez J; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Camarillo JM; Department of Chemistry, Molecular Biosciences and the National Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, IL 60208, USA., Takata K; Center for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC V5Z 1L3, Canada., Tarte K; UMR 1236, Université Rennes 1, INSERM, Etablissement Français du Sang, 35043 Rennes, France., Kelleher NL; Department of Chemistry, Molecular Biosciences and the National Resource for Translational and Developmental Proteomics, Northwestern University, Evanston, IL 60208, USA., Steidl C; Center for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC V5Z 1L3, Canada., Mason CE; Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY 10021, USA; The Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10021, USA., Elemento O; Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA., Allis CD; Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY 10065, USA., Kleinstein SH; Department of Pathology, Yale School of Medicine, New Haven, CT 06520, USA; Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511, USA., Melnick AM; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA. Electronic address: amm2014@med.cornell.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2020 May 11; Vol. 37 (5), pp. 655-673.e11.
Autor:
Dominguez PM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York., Ghamlouch H; INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Rosikiewicz W; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Kumar P; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut., Béguelin W; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York., Fontán L; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York., Rivas MA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York., Pawlikowska P; CNRS UMR8200, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Armand M; INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; CNRS UMR8200, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Mouly E; INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Torres-Martin M; Sylvester Comprehensive Cancer Center, Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida., Doane AS; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York.; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York., Calvo Fernandez MT; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York., Durant M; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York., Della-Valle V; INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Teater M; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York.; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York., Cimmino L; Department of Pathology, Laura and Isaac Perlmutter Cancer Center, and The Helen L. and Martin S. Kimmel Center for Stem Cell Biology, NYU School of Medicine, New York, New York., Droin N; INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Tadros S; Department of Lymphoma/Myeloma and Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Motanagh S; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Shih AH; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Rubin MA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Tam W; Pathology and Laboratory Medicine Department, Weill Cornell Medicine, New York, New York., Aifantis I; Department of Pathology, Laura and Isaac Perlmutter Cancer Center, and The Helen L. and Martin S. Kimmel Center for Stem Cell Biology, NYU School of Medicine, New York, New York., Levine RL; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York., Elemento O; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York., Inghirami G; Pathology and Laboratory Medicine Department, Weill Cornell Medicine, New York, New York., Green MR; Department of Lymphoma/Myeloma and Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Figueroa ME; Sylvester Comprehensive Cancer Center, Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida., Bernard OA; INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France. amm2014@med.cornell.edu olivier.bernard@inserm.fr Said.AOUFOUCHI@gustaveroussy.fr sheng.li@jax.org rshaknovich@gmail.com., Aoufouchi S; CNRS UMR8200, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France. amm2014@med.cornell.edu olivier.bernard@inserm.fr Said.AOUFOUCHI@gustaveroussy.fr sheng.li@jax.org rshaknovich@gmail.com., Li S; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut. amm2014@med.cornell.edu olivier.bernard@inserm.fr Said.AOUFOUCHI@gustaveroussy.fr sheng.li@jax.org rshaknovich@gmail.com.; The Jackson Laboratory Cancer Center, Bar Harbor, Maine.; Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, Connecticut., Shaknovich R; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York. amm2014@med.cornell.edu olivier.bernard@inserm.fr Said.AOUFOUCHI@gustaveroussy.fr sheng.li@jax.org rshaknovich@gmail.com.; Cancer Genetics, Inc., Rutherford, New Jersey., Melnick AM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York. amm2014@med.cornell.edu olivier.bernard@inserm.fr Said.AOUFOUCHI@gustaveroussy.fr sheng.li@jax.org rshaknovich@gmail.com.
Publikováno v:
Cancer discovery [Cancer Discov] 2018 Dec; Vol. 8 (12), pp. 1632-1653. Date of Electronic Publication: 2018 Oct 01.
Autor:
Béguelin W; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA. web2002@med.cornell.edu., Rivas MA; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA., Calvo Fernández MT; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA., Teater M; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA., Purwada A; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA., Redmond D; Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA., Shen H; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA., Challman MF; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA., Elemento O; Institute for Computational Biomedicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA., Singh A; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA. as2833@cornell.edu.; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, NY, 14853, USA. as2833@cornell.edu., Melnick AM; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, 10021, USA. amm2014@med.cornell.edu.
Publikováno v:
Nature communications [Nat Commun] 2017 Oct 12; Vol. 8 (1), pp. 877. Date of Electronic Publication: 2017 Oct 12.
Autor:
Béguelin W; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Teater M; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA; Institute for Computational Biomedicine, Weill Cornell Medical College, Cornell University, New York, NY 10021, USA., Gearhart MD; Department of Genetics, Cell Biology, and Development, Developmental Biology Center, Masonic Cancer Center, University of Minnesota, 6-160 Church Street SE, University of Minnesota, Minneapolis, MN 55455, USA., Calvo Fernández MT; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Goldstein RL; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Cárdenas MG; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Hatzi K; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Rosen M; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Shen H; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Corcoran CM; Department of Genetics, Cell Biology, and Development, Developmental Biology Center, Masonic Cancer Center, University of Minnesota, 6-160 Church Street SE, University of Minnesota, Minneapolis, MN 55455, USA., Hamline MY; Department of Genetics, Cell Biology, and Development, Developmental Biology Center, Masonic Cancer Center, University of Minnesota, 6-160 Church Street SE, University of Minnesota, Minneapolis, MN 55455, USA., Gascoyne RD; Departments of Pathology and Lymphoid Cancer Research, Centre for Lymphoid Cancer, British Columbia Cancer Agency, British Columbia Cancer Research Centre, Vancouver, BC, V5Z 1L3, Canada., Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA., Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA., Licht JD; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA., Shaknovich R; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA., Elemento O; Institute for Computational Biomedicine, Weill Cornell Medical College, Cornell University, New York, NY 10021, USA., Bardwell VJ; Department of Genetics, Cell Biology, and Development, Developmental Biology Center, Masonic Cancer Center, University of Minnesota, 6-160 Church Street SE, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: bardw001@umn.edu., Melnick AM; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, Cornell University, 413 E 69(th) Street, New York, NY 10021, USA. Electronic address: amm2014@med.cornell.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2016 Aug 08; Vol. 30 (2), pp. 197-213.
Publikováno v:
Revista panamericana de salud publica = Pan American journal of public health [Rev Panam Salud Publica] 2016 Aug; Vol. 40 (1), pp. 70-75.
Autor:
García-García C; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Rivas MA; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Ibrahim YH; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Calvo MT; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Gris-Oliver A; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Rodríguez O; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Grueso J; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Antón P; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Guzmán M; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Aura C; Molecular Pathology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Nuciforo P; Molecular Pathology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Jessen K; Takeda California, San Diego, CA 92121., Argilés G; Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Dienstmann R; Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Bertotti A; Department of Oncology, University of Torino School of Medicine, 10060 Candiolo, Torino, Italy.; Translational Cancer Medicine, Candiolo Cancer Institute - FPO IRCCS, 10060 Candiolo, Torino, Italy., Trusolino L; Department of Oncology, University of Torino School of Medicine, 10060 Candiolo, Torino, Italy.; Translational Cancer Medicine, Candiolo Cancer Institute - FPO IRCCS, 10060 Candiolo, Torino, Italy., Matito J; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Chicote I; Stem Cells and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Palmer HG; Stem Cells and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain., Tabernero J; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain.; Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Scaltriti M; Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065., Baselga J; Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.; Breast Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065., Serra V; Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), 08035-Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Dec 15; Vol. 21 (24), pp. 5499-5510. Date of Electronic Publication: 2015 Aug 13.
Autor:
Andrés R; Servicio de Oncología Médica, Hospital Clínico Lozano Blesa, San Juan bosco 15, 50009, Zaragoza, Spain, andresraquel@hotmail.com., Pajares I, Balmaña J, Llort G, Ramón Y Cajal T, Chirivella I, Aguirre E, Robles L, Lastra E, Pérez-Segura P, Bosch N, Yagüe C, Lerma E, Godino J, Miramar MD, Moros M, Astier P, Saez B, Vidal MJ, Arcusa A, Ramón y Cajal S, Calvo MT, Tres A
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2014 Mar; Vol. 16 (3), pp. 280-4. Date of Electronic Publication: 2013 Aug 27.